Answers are grounded in this paper and cite their sources.
Registry evaluation identifies specific criteria for nonrelapsing SPMS patients, highlighting clinical implications.
HERCULES-adapted criteria identified a subgroup of 7.9% nrSPMS patients in the real-world cohort of RISM, characterized by fewer post-conversion relapses and earlier PIRA onset. These findings reinforce the value of applying standardized algorithmic definitions of SPMS in registry-based studies.
No takes yet. Share an insight, caveat, or question.
Guerra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: